HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 56 filers reported holding HILLEVAX INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,316,776 | -16.4% | 172,251 | +6.9% | 0.00% | -100.0% |
| Q2 2023 | $2,769,842 | +26.0% | 161,131 | +21.1% | 0.00% | – |
| Q1 2023 | $2,198,738 | -4.0% | 133,015 | -2.9% | 0.00% | – |
| Q4 2022 | $2,291,541 | +29.5% | 136,972 | +32.2% | 0.00% | – |
| Q3 2022 | $1,770,000 | +54.6% | 103,580 | -1.1% | 0.00% | – |
| Q2 2022 | $1,145,000 | – | 104,745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 558,923 | $9,552,000 | 13.88% |
| Frazier Life Sciences Management, L.P. | 9,758,359 | $166,770,000 | 12.84% |
| Abingworth LLP | 1,838,486 | $31,401,000 | 10.74% |
| Samsara BioCapital, LLC | 610,062 | $10,426,000 | 2.43% |
| StepStone Group LP | 676,567 | $11,563,000 | 1.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,653,231 | $45,344,000 | 0.90% |
| RA Capital Management | 1,760,019 | $30,079,000 | 0.64% |
| Perceptive Advisors | 764,907 | $13,072,000 | 0.38% |
| BVF INC/IL | 382,452 | $6,536,000 | 0.27% |
| Sandia Investment Management LP | 7,900 | $135,000 | 0.02% |